Code intelligence

LCD-L40259 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code LCD-L40259.

Critical code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Critical

Critical

100%

High

Routine

Low

New this month

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

LCD L40259: MolDX: Genetic Testing for Hereditary Thrombophilia — CGS

Policy LCD-L40259 · Clinical Laboratory

Critical

This final LCD from CGS (J15) establishes coverage criteria for genetic testing related to hereditary thrombophilia under the MolDX program, effective October 12, 2026, for Kentucky and Ohio providers

View alert

Audit documentation

Building an audit file that includes LCD-L40259?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription